MOONLAKE IMMUNOTHERAPEUTICS
Ownership & governance
Executives 5Directors 5Avg age 53Avg tenure 3.6y
JS
Jorge da Silva
Chief Executive Officer
Age 49Since 2022-04-04Profile →
+9
Executives5
JS
Jorge da Silva→
Chief Executive Officer
Age 49Since 2022-04-04
KR
Kristian Reich→
Chief Tech/Sci/R&D Officer
Age 60Since 2022-04-04
MB
Matthias Bodenstedt→
Director of Finance/CFO
Age 38Since 2022-04-04
EC
Eva Cullen→
Chief Tech/Sci/R&D Officer
—Since 2021-07-31
JC
Joana Cortez→
Compliance Officer
—Since 2023-12-31
Board of directors5
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| BVF, Inc. | 21.74 % | 16,001,284 |
| BVF Partners LP | 21.74 % | 16,001,284 |
| Deep Track Capital LP | 8.706 % | 6,408,863 |
| Cormorant Asset Management LP | 6.086 % | 4,480,433 |
| Janus Henderson Investors US LLC | 4.689 % | 3,451,628 |
Catalog · 2026-07-09
Registry officers10
| Name | Role | Since | Shares |
|---|---|---|---|
| Eva Cullen | Chief Tech/Sci/R&D Officer | 2021-07-31 | - |
| Jorge da Silva | Chief Executive Officer | 2022-04-04 | - |
| Jorge da Silva | Chairman | 2026-02-27 | - |
| Kristian Reich | Chief Tech/Sci/R&D Officer | 2022-04-04 | - |
| Matthias Bodenstedt | Director of Finance/CFO | 2022-04-04 | - |
| Andrew Phillips | Director/Board Member | 2022-04-04 | - |
| Catherine Moukheibir | Director/Board Member | 2022-04-04 | - |
| Ramnik Xavier | Director/Board Member | 2022-04-04 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus buyMean target 28.54Range 6–50Analysts 13
6Mean 28.5450
- Strong buy 1
- Buy 10
- Hold 2
- Sell 2
Broker actions40 of 121
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterated | Buy | 50 | 2026-10-05 |
| HC Wainwright & Co. | Maintained | Buy | 50 | 2026-08-13 |
| HC Wainwright & Co. | Reiterated | Buy | 45 | 2026-07-20 |
| Leerink Partners | Maintained | Outperform | 29 | 2026-07-01 |
| BTIG | Reiterated | Buy | 30 | 2026-06-09 |
| HC Wainwright & Co. | Reiterated | Buy | 45 | 2026-06-08 |
| Needham | Maintained | Buy | 30 | 2026-05-12 |
| HC Wainwright & Co. | Maintained | Buy | 45 | 2026-05-11 |
| BTIG | Reiterated | Buy | 30 | 2026-03-30 |
| Wolfe Research | Upgrade | Outperform | 24 | 2026-03-23 |
| Rothschild & Co | Upgrade | Buy | 40 | 2026-03-19 |
| Clear Street | Maintained | Buy | 70 | 2026-03-11 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.